| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glutathione | 10 | 2020 | 200 | 3.610 |
Why?
|
| Fluorescent Dyes | 6 | 2020 | 246 | 1.950 |
Why?
|
| Nuclear Receptor Coactivator 3 | 6 | 2021 | 257 | 1.700 |
Why?
|
| Molecular Imaging | 3 | 2018 | 58 | 1.430 |
Why?
|
| Oxidation-Reduction | 7 | 2021 | 436 | 1.000 |
Why?
|
| Sulfhydryl Compounds | 2 | 2015 | 53 | 0.850 |
Why?
|
| Polyethylene Glycols | 4 | 2013 | 235 | 0.820 |
Why?
|
| Epoxy Compounds | 1 | 2021 | 18 | 0.680 |
Why?
|
| Flow Cytometry | 2 | 2020 | 765 | 0.670 |
Why?
|
| Nanoparticles | 4 | 2013 | 310 | 0.670 |
Why?
|
| Macrolides | 1 | 2021 | 31 | 0.670 |
Why?
|
| Spliceosomes | 1 | 2021 | 47 | 0.660 |
Why?
|
| Intracellular Space | 3 | 2020 | 46 | 0.650 |
Why?
|
| Computer Systems | 1 | 2020 | 35 | 0.650 |
Why?
|
| HeLa Cells | 8 | 2018 | 686 | 0.610 |
Why?
|
| RNAi Therapeutics | 1 | 2018 | 17 | 0.570 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 664 | 0.560 |
Why?
|
| Bufanolides | 2 | 2015 | 13 | 0.560 |
Why?
|
| Azides | 3 | 2008 | 11 | 0.550 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 305 | 0.550 |
Why?
|
| Molecular Probes | 1 | 2018 | 25 | 0.540 |
Why?
|
| Mustard Gas | 1 | 2017 | 3 | 0.540 |
Why?
|
| Chemical Warfare Agents | 1 | 2017 | 6 | 0.540 |
Why?
|
| Keratinocytes | 1 | 2017 | 71 | 0.520 |
Why?
|
| Cell Survival | 8 | 2020 | 826 | 0.520 |
Why?
|
| Cell Line, Tumor | 13 | 2021 | 3748 | 0.520 |
Why?
|
| Fluorometry | 1 | 2017 | 27 | 0.510 |
Why?
|
| Biosensing Techniques | 1 | 2018 | 81 | 0.500 |
Why?
|
| Cell Proliferation | 7 | 2021 | 2465 | 0.500 |
Why?
|
| Antioxidants | 2 | 2020 | 331 | 0.480 |
Why?
|
| Hydrogen Sulfide | 1 | 2016 | 8 | 0.480 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 196 | 0.470 |
Why?
|
| Hydrazones | 1 | 2016 | 14 | 0.470 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 142 | 0.460 |
Why?
|
| Genetic Techniques | 1 | 2016 | 95 | 0.450 |
Why?
|
| Prodrugs | 1 | 2015 | 56 | 0.450 |
Why?
|
| Molecular Structure | 8 | 2018 | 315 | 0.440 |
Why?
|
| Benzimidazoles | 1 | 2016 | 161 | 0.440 |
Why?
|
| Epithelial Cells | 2 | 2016 | 905 | 0.410 |
Why?
|
| Nanotechnology | 2 | 2012 | 50 | 0.410 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 21 | 0.400 |
Why?
|
| Microsomes, Liver | 3 | 2020 | 97 | 0.380 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 740 | 0.370 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 280 | 0.360 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 1826 | 0.350 |
Why?
|
| Nanomedicine | 1 | 2011 | 33 | 0.330 |
Why?
|
| Nuclear Receptor Coactivator 1 | 3 | 2017 | 161 | 0.330 |
Why?
|
| Receptors, Transferrin | 1 | 2010 | 11 | 0.330 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2020 | 354 | 0.300 |
Why?
|
| Imines | 2 | 2015 | 9 | 0.290 |
Why?
|
| Biomarkers | 1 | 2018 | 3385 | 0.290 |
Why?
|
| Naphthalenes | 2 | 2016 | 37 | 0.290 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2010 | 163 | 0.290 |
Why?
|
| Methane | 1 | 2008 | 16 | 0.280 |
Why?
|
| Microscopy, Confocal | 2 | 2020 | 335 | 0.280 |
Why?
|
| Phenylacetates | 1 | 2008 | 26 | 0.280 |
Why?
|
| Ketones | 1 | 2008 | 25 | 0.280 |
Why?
|
| 3T3-L1 Cells | 2 | 2020 | 54 | 0.270 |
Why?
|
| Mice | 16 | 2021 | 18301 | 0.270 |
Why?
|
| Kinetics | 3 | 2017 | 1088 | 0.270 |
Why?
|
| Animals | 20 | 2021 | 33912 | 0.270 |
Why?
|
| Imides | 1 | 2007 | 1 | 0.270 |
Why?
|
| Glutaredoxins | 2 | 2019 | 31 | 0.260 |
Why?
|
| Benzene Derivatives | 1 | 2007 | 20 | 0.260 |
Why?
|
| Mice, SCID | 3 | 2018 | 585 | 0.260 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 521 | 0.240 |
Why?
|
| Breast Neoplasms | 4 | 2021 | 2602 | 0.220 |
Why?
|
| Humans | 28 | 2021 | 131163 | 0.210 |
Why?
|
| Transfection | 3 | 2017 | 962 | 0.210 |
Why?
|
| Ultraviolet Rays | 2 | 2008 | 192 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 2026 | 0.200 |
Why?
|
| Mice, Nude | 3 | 2021 | 700 | 0.190 |
Why?
|
| Amides | 1 | 2003 | 81 | 0.190 |
Why?
|
| Cell Line | 5 | 2020 | 2552 | 0.180 |
Why?
|
| Thermodynamics | 2 | 2015 | 147 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 978 | 0.170 |
Why?
|
| Plant Physiological Phenomena | 1 | 2021 | 7 | 0.170 |
Why?
|
| Reference Standards | 2 | 2020 | 231 | 0.170 |
Why?
|
| Myelin and Lymphocyte-Associated Proteolipid Proteins | 1 | 2021 | 2 | 0.170 |
Why?
|
| Carboxy-Lyases | 1 | 2021 | 16 | 0.170 |
Why?
|
| Oxalates | 1 | 2021 | 22 | 0.170 |
Why?
|
| Sulfonamides | 1 | 2003 | 296 | 0.170 |
Why?
|
| Stereoisomerism | 1 | 2021 | 106 | 0.170 |
Why?
|
| Antigen Presentation | 1 | 2021 | 110 | 0.160 |
Why?
|
| Cell Size | 1 | 2020 | 77 | 0.160 |
Why?
|
| Models, Molecular | 3 | 2021 | 1064 | 0.160 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2020 | 22 | 0.160 |
Why?
|
| Calibration | 1 | 2020 | 92 | 0.160 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2020 | 36 | 0.160 |
Why?
|
| Tumor Escape | 1 | 2021 | 65 | 0.160 |
Why?
|
| Neurogenic Inflammation | 1 | 2020 | 4 | 0.160 |
Why?
|
| Stem Cell Niche | 1 | 2020 | 55 | 0.160 |
Why?
|
| Signal Transduction | 5 | 2021 | 4686 | 0.160 |
Why?
|
| Staining and Labeling | 1 | 2020 | 166 | 0.160 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 45 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2019 | 137 | 0.150 |
Why?
|
| Arabidopsis | 1 | 2021 | 93 | 0.150 |
Why?
|
| DNA | 2 | 2015 | 1399 | 0.150 |
Why?
|
| Transcription, Genetic | 4 | 2018 | 1363 | 0.150 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 167 | 0.150 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 208 | 0.150 |
Why?
|
| Oxidative Stress | 3 | 2020 | 791 | 0.150 |
Why?
|
| Haploidy | 1 | 2019 | 17 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 1011 | 0.150 |
Why?
|
| Multiple Myeloma | 1 | 2021 | 177 | 0.140 |
Why?
|
| Biological Products | 1 | 2021 | 145 | 0.140 |
Why?
|
| Mice, Inbred ICR | 2 | 2016 | 138 | 0.140 |
Why?
|
| Microglia | 1 | 2020 | 147 | 0.140 |
Why?
|
| RNA Polymerase II | 1 | 2018 | 83 | 0.140 |
Why?
|
| Cardiomegaly | 1 | 2019 | 117 | 0.140 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 393 | 0.140 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2008 | 40 | 0.140 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 573 | 0.130 |
Why?
|
| Tumor Burden | 1 | 2018 | 240 | 0.130 |
Why?
|
| NADP | 1 | 2017 | 57 | 0.130 |
Why?
|
| Single-Cell Analysis | 2 | 2020 | 350 | 0.130 |
Why?
|
| NAD | 1 | 2017 | 52 | 0.130 |
Why?
|
| Drug Resistance, Multiple | 1 | 2017 | 57 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 588 | 0.130 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 248 | 0.130 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2018 | 105 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 363 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 631 | 0.120 |
Why?
|
| Protein Conformation | 2 | 2021 | 732 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 680 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2021 | 760 | 0.120 |
Why?
|
| Receptors, Melatonin | 1 | 2016 | 2 | 0.120 |
Why?
|
| Multiple Sclerosis | 1 | 2020 | 395 | 0.120 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2020 | 544 | 0.120 |
Why?
|
| Acetamides | 1 | 2016 | 43 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 821 | 0.120 |
Why?
|
| Serum Albumin, Bovine | 2 | 2013 | 37 | 0.120 |
Why?
|
| Mannose | 1 | 2015 | 25 | 0.120 |
Why?
|
| Longevity | 1 | 2017 | 178 | 0.110 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 104 | 0.110 |
Why?
|
| Aldehydes | 1 | 2015 | 27 | 0.110 |
Why?
|
| Caenorhabditis elegans | 1 | 2017 | 251 | 0.110 |
Why?
|
| Lactation | 1 | 2016 | 195 | 0.110 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2015 | 50 | 0.110 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 110 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 90 | 0.110 |
Why?
|
| Cell Movement | 1 | 2018 | 876 | 0.110 |
Why?
|
| Ligands | 2 | 2020 | 481 | 0.110 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 83 | 0.110 |
Why?
|
| Polymers | 1 | 2015 | 103 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 132 | 0.110 |
Why?
|
| Estrogen Receptor alpha | 1 | 2018 | 431 | 0.110 |
Why?
|
| Female | 12 | 2021 | 70963 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 330 | 0.110 |
Why?
|
| Oxygen | 1 | 2018 | 548 | 0.110 |
Why?
|
| Plasmids | 1 | 2015 | 449 | 0.110 |
Why?
|
| Aging | 2 | 2019 | 1242 | 0.100 |
Why?
|
| Quinazolines | 1 | 2015 | 176 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 227 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 359 | 0.100 |
Why?
|
| Esterification | 1 | 2013 | 13 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 325 | 0.100 |
Why?
|
| Mammary Glands, Animal | 1 | 2016 | 448 | 0.100 |
Why?
|
| Oligonucleotides | 1 | 2013 | 94 | 0.100 |
Why?
|
| Jurkat Cells | 1 | 2013 | 83 | 0.100 |
Why?
|
| Apoptosis | 3 | 2021 | 1827 | 0.100 |
Why?
|
| Folic Acid | 1 | 2015 | 269 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1801 | 0.100 |
Why?
|
| RNA | 2 | 2013 | 517 | 0.100 |
Why?
|
| Cattle | 2 | 2012 | 501 | 0.090 |
Why?
|
| Microtechnology | 1 | 2012 | 6 | 0.090 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2012 | 24 | 0.090 |
Why?
|
| MCF-7 Cells | 3 | 2018 | 209 | 0.090 |
Why?
|
| Delayed-Action Preparations | 1 | 2012 | 123 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 732 | 0.090 |
Why?
|
| Time Factors | 4 | 2012 | 6196 | 0.090 |
Why?
|
| Escherichia coli | 1 | 2017 | 991 | 0.090 |
Why?
|
| Cells | 1 | 2011 | 20 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2012 | 124 | 0.090 |
Why?
|
| Macrophages | 1 | 2015 | 667 | 0.080 |
Why?
|
| Photochemistry | 2 | 2008 | 21 | 0.080 |
Why?
|
| Endocytosis | 1 | 2011 | 121 | 0.080 |
Why?
|
| Tissue Distribution | 1 | 2011 | 358 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 633 | 0.080 |
Why?
|
| Drug Design | 1 | 2011 | 156 | 0.080 |
Why?
|
| Biological Transport | 1 | 2010 | 329 | 0.080 |
Why?
|
| Lipids | 1 | 2013 | 569 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 437 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 1591 | 0.070 |
Why?
|
| Metabolomics | 3 | 2020 | 501 | 0.070 |
Why?
|
| Mice, Knockout | 4 | 2020 | 3819 | 0.070 |
Why?
|
| Diazonium Compounds | 1 | 2008 | 2 | 0.070 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2008 | 23 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2008 | 78 | 0.070 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2008 | 23 | 0.070 |
Why?
|
| Spectrophotometry | 1 | 2007 | 42 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2021 | 192 | 0.070 |
Why?
|
| Translocation, Genetic | 2 | 2021 | 344 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1590 | 0.070 |
Why?
|
| Azepines | 1 | 2008 | 62 | 0.070 |
Why?
|
| Quantum Theory | 1 | 2007 | 19 | 0.070 |
Why?
|
| Ions | 1 | 2007 | 25 | 0.070 |
Why?
|
| Heart Failure | 1 | 2019 | 2332 | 0.060 |
Why?
|
| Protein Binding | 2 | 2020 | 1652 | 0.060 |
Why?
|
| Isoenzymes | 2 | 2016 | 211 | 0.060 |
Why?
|
| Molecular Conformation | 1 | 2003 | 96 | 0.050 |
Why?
|
| DNA, Superhelical | 1 | 2003 | 24 | 0.050 |
Why?
|
| Gene Silencing | 2 | 2015 | 229 | 0.050 |
Why?
|
| Particle Size | 2 | 2013 | 135 | 0.050 |
Why?
|
| Distamycins | 1 | 2002 | 1 | 0.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2002 | 58 | 0.040 |
Why?
|
| Plant Development | 1 | 2021 | 6 | 0.040 |
Why?
|
| Proteasome Inhibitors | 1 | 2021 | 52 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2021 | 53 | 0.040 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2021 | 65 | 0.040 |
Why?
|
| Bortezomib | 1 | 2021 | 70 | 0.040 |
Why?
|
| Organic Chemistry Phenomena | 1 | 2020 | 3 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4738 | 0.040 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2020 | 17 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2021 | 94 | 0.040 |
Why?
|
| Half-Life | 1 | 2020 | 149 | 0.040 |
Why?
|
| Acrylamides | 1 | 2020 | 28 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 109 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2020 | 149 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2021 | 318 | 0.040 |
Why?
|
| Isoxazoles | 1 | 2020 | 32 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 135 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 576 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2021 | 780 | 0.040 |
Why?
|
| Protein Transport | 1 | 2021 | 366 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 155 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 356 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 134 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 200 | 0.040 |
Why?
|
| Ribonucleoprotein, U4-U6 Small Nuclear | 1 | 2019 | 1 | 0.040 |
Why?
|
| N-Terminal Acetyltransferase C | 1 | 2019 | 2 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 119 | 0.040 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2019 | 38 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2021 | 308 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 189 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2018 | 292 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 463 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 373 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2017 | 34 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2020 | 406 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1483 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2019 | 243 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 407 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 66 | 0.030 |
Why?
|
| Histones | 1 | 2021 | 541 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2395 | 0.030 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2016 | 16 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1489 | 0.030 |
Why?
|
| Mitochondrial Dynamics | 1 | 2017 | 56 | 0.030 |
Why?
|
| Male | 5 | 2021 | 64957 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2016 | 106 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 419 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2016 | 51 | 0.030 |
Why?
|
| Pregnancy, Animal | 1 | 2016 | 66 | 0.030 |
Why?
|
| Semicarbazides | 1 | 2016 | 3 | 0.030 |
Why?
|
| Milk Proteins | 1 | 2016 | 95 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2018 | 516 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 619 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2017 | 143 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2017 | 106 | 0.030 |
Why?
|
| Biotransformation | 1 | 2016 | 54 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2002 | 807 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 129 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2017 | 2406 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2017 | 229 | 0.030 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2015 | 9 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 254 | 0.030 |
Why?
|
| Cytochrome P-450 CYP3A Inhibitors | 1 | 2015 | 10 | 0.030 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2015 | 14 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2015 | 53 | 0.030 |
Why?
|
| Models, Animal | 1 | 2017 | 450 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 223 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 104 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 801 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 1013 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 386 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2016 | 440 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 526 | 0.030 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2015 | 135 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 767 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3370 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2015 | 235 | 0.030 |
Why?
|
| Calorimetry | 1 | 2013 | 63 | 0.030 |
Why?
|
| Proteomics | 1 | 2018 | 615 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2015 | 286 | 0.030 |
Why?
|
| Bioengineering | 1 | 2013 | 15 | 0.030 |
Why?
|
| Digoxin | 1 | 2014 | 37 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 2013 | 22 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 129 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2013 | 33 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 668 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2019 | 2885 | 0.020 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2013 | 49 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2018 | 993 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 677 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 713 | 0.020 |
Why?
|
| Feces | 1 | 2016 | 721 | 0.020 |
Why?
|
| Disulfides | 1 | 2012 | 60 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 117 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 950 | 0.020 |
Why?
|
| Vero Cells | 1 | 2012 | 115 | 0.020 |
Why?
|
| Luciferases | 1 | 2012 | 127 | 0.020 |
Why?
|
| Genome, Human | 1 | 2019 | 1321 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 1207 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1319 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2013 | 344 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2012 | 249 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2550 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1833 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6797 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4697 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 2200 | 0.020 |
Why?
|
| Acetonitriles | 1 | 2008 | 3 | 0.020 |
Why?
|
| Photolysis | 1 | 2008 | 10 | 0.020 |
Why?
|
| Solutions | 1 | 2008 | 50 | 0.020 |
Why?
|
| Dimerization | 1 | 2008 | 137 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2323 | 0.020 |
Why?
|
| Water | 1 | 2008 | 186 | 0.020 |
Why?
|
| Mutation | 1 | 2020 | 6099 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 7512 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 21025 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 28601 | 0.010 |
Why?
|
| Imidazoles | 1 | 2002 | 219 | 0.010 |
Why?
|
| Pyrroles | 1 | 2002 | 188 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 31282 | 0.010 |
Why?
|